当前位置: 首页 > 期刊 > 《中国医学人文杂志》 > 20134
编号:13733676
Caveolin—3基因在疾病中的初步研究(3)
http://www.100md.com 2013年4月1日 《维吾尔医药》 20134
     [14]Sotgia F,Bonuccelli G,Minetti C,et al. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting:implications for the pathogenesis of caveolin-related muscle diseases[J].Am J Pathol. 2003,163(6):2619-34.

    [15]Scherer PE, Lisanti MP. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes. Dynamic regulation by extracellular glucose and intracellular metabolites[J].J Biol Chem.1997,272(33):20698-705.

    [16]Fuller W, Eaton P, Medina RA, et al. Differential centrifugation separates cardiac sarcolemmal and endosomal membranes from Langendorff-perfused rat hearts[J].Anal Biochem.2001, 15,293(2):216-223.

    [17]Bossuyt J,Taylor BE,James-Kracke M, et al.The cardiac sodium-calcium exchanger associates with caveolin-3[J].Ann N Y Acad Sci.2002,976:197-204.

    [18]Oshikawa J,Otsu K,Toya Y,et al.Insulin resistance in skeletal muscles of caveolin-3-null mice[J]. Proc Natl Acad Sci U S A. 2004,101(34):12670-12675.

    [19]Capozza F, Combs TP, Cohen AW,et al.Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle[J].Am J Physiol Cell Physiol. 2005,288(6):C1317-31.

    [20] 马静,路文盛,莫书荣,黄媛恒,黄娟娟,杨立会,黄勤..广西壮族caveolin-3基因多态性与2型糖尿病的关联分析[J].山东医药,2011,23(17):36-37., 百拇医药(马静 黄娟娟 陈睿)
上一页1 2 3